Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma.
about
Mouse models of acute exacerbations of allergic asthmaCXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infectionPathways activated during human asthma exacerbation as revealed by gene expression patterns in bloodCXCL5 drives obesity to diabetes, and further.Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma.Effect of activation of Toll-like receptor 7 in the inhibition of allergic asthma on a mouse modelRespiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations.The airway epithelium: soldier in the fight against respiratory virusesIntranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine modelEpithelial cells, the "switchboard" of respiratory immune defense responses: effects of air pollutants.CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations.Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjectsCXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BETComprehensive evaluation of poly(I:C) induced inflammatory response in an airway epithelial modelApolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism.Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPDIL-17-producing peripheral blood CD177+ neutrophils increase in allergic asthmatic subjectsChemotaxis, chemokine receptors and human disease.T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia.Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.Resolution of cell-mediated airways diseases.Targeting chemokine receptors in allergic disease.Immunomodulatory oligonucleotides inhibit neutrophil migration by decreasing the surface expression of interleukin-8 and leukotriene B4 receptors.Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma.The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review.Sesamin suppresses macrophage-derived chemokine expression in human monocytes via epigenetic regulation.Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma.Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.Effects of vitamin D3 on the expression of growth-related oncogene-α in THP-1 cells and human primary monocytes.Near fatal asthma: clinical and airway biopsy characteristicsThe laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma.Plasmacytoid dendritic cells in allergic asthma and the role of inhaled corticosteroid treatment.CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model.Expression Profile of the Immune Response Factors in Patients with Bronchial Asthma
P2860
Q26765990-CC69312F-7203-41B9-99EA-7E0069E8ECABQ28589805-B482B582-8BAB-4126-B125-293CCF183150Q28742613-838CBC29-81C4-4852-8443-5E51E058D5FEQ33588773-572F1A36-3EA6-421A-AEBF-0CFD58495125Q33702608-5ACF9115-23F2-4215-B616-D60F4447B8B2Q33733105-A134DC81-EE5D-4775-956C-06CC11AB0AD2Q34066715-3A680229-23E7-4C23-87BB-6A1D4A244B3CQ34491598-09D2A1AB-0386-4E63-964F-2E93F7EC9F06Q34704284-309B816F-8911-4F26-B832-582BD2368E70Q35134068-F752707D-6FD3-4008-B5B7-5F369D866924Q35495112-96C57E8E-7C70-4EFD-B6AD-003B52F72B72Q35560440-AAB2AA53-5963-425F-B981-EC154FCBA2A0Q35574709-4BD8AE17-5DA3-44A4-A6A3-C9DDC183CC0BQ35588587-A8513461-6D88-4160-9FBD-161B748F8E2EQ36176942-ADE26F41-4FA7-471D-A8CC-58B7CEE85A5FQ36181801-1E31F7EA-B15D-4DB3-836D-C2521B76CCC1Q36992643-7ADCC147-AC15-414B-ABCF-319F1F18A5EEQ37034783-4DDD3069-6CDC-4FB8-8BDF-AD0DEA45C1FBQ37292433-548DAB92-F744-49C7-8007-A22B68E4D684Q37419522-1D21285D-1C53-43C0-A497-160554BAF8D1Q37700876-A56AE66F-1C0C-4649-81A2-77F7AB98A7A6Q37764375-AC85506D-B446-45AB-86EE-FB9F255B36E6Q37832529-FB8F0329-EE60-4F3E-97BE-A125A7FBA6E5Q38305188-6A709905-3603-48D5-9489-A2372DD9606BQ38314318-15F4B4B7-20E9-4423-AC11-794891399BEBQ38707472-A0374854-275A-490C-A5FC-9E1198463C4DQ38966673-ECC94BE8-6780-4B0F-A25B-63E165DB0575Q39042664-368A1DB5-E3A5-447F-911B-4222EE086C8BQ39321350-5E83F36F-9EC9-4311-908A-540736582BE5Q39411190-580B5A86-FC72-4D7A-B549-B9CDCF692761Q42625216-380DEF62-BA30-471C-A8E2-5B929C676995Q42764737-F1611B1A-C087-48A7-8A5B-5DD1342A8A50Q45985826-DD629415-20A8-40A0-8AA8-9B114FA5F078Q46586534-D5E038D0-4964-4240-9B89-1947E1634933Q58050578-2F393624-FFE5-4733-9AC8-12E5EA646E1F
P2860
Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bronchial mucosal inflammation ...... evere exacerbations of asthma.
@ast
Bronchial mucosal inflammation ...... evere exacerbations of asthma.
@en
type
label
Bronchial mucosal inflammation ...... evere exacerbations of asthma.
@ast
Bronchial mucosal inflammation ...... evere exacerbations of asthma.
@en
prefLabel
Bronchial mucosal inflammation ...... evere exacerbations of asthma.
@ast
Bronchial mucosal inflammation ...... evere exacerbations of asthma.
@en
P2093
P2860
P356
P1433
P1476
Bronchial mucosal inflammation ...... evere exacerbations of asthma.
@en
P2093
Kay K Guntupalli
Peter K Jeffery
Venkata Bandi
Yusheng Qiu
P2860
P304
P356
10.1136/THX.2006.066670
P407
P577
2007-01-18T00:00:00Z